medigraphic.com
ISSN 1527-3172 (Electronic)

2020, Number 4

<< Back Next >>

MEDICC Review 2020; 22 (4)

Characterization of Deaths from Cirrhosis of the Liver in Cuba, 1987–2017

Pedroso-Flaquet P, Alfonso-Sagué K, Venero-Fernández SJ

Language: English
References: 30
Page: 35-39
PDF size: 141.32 Kb.


ABSTRACT

INTRODUCTION Cirrhosis of the liver is a chronic disease that is widespread and irreversible. It represents the fi nal stage of numerous diseases that affect the liver. By the end of 2017, it was the 11th most common cause of death, with a loss of 41.4 million years of disability-adjusted life years, which represent 2.1% of the total years of life lost in the global mortality burden. In Cuba, cirrhosis and other chronic liver diseases have been among the top 10 causes of death for several decades, their rates consistently increasing, from 576 deaths in 1970 (6.7 per 100,000 population) to 1738 in 2017 (15.5 per 100,000 population), with a risk of death that is 4.6 times higher in men.
OBJECTIVE Characterize deaths from cirrhosis of the liver in Cuba from 1987 to 2017.
METHODS An ecological time-series study was conducted for 1987 to 2017 using information obtained from the mortality database of the Medical Records and Health Statistics Bureau of Cuba’s Ministry of Public Health. The study universe consisted of all deceased persons in the country whose underlying cause of death was cirrhosis of the liver. Both general mortality rates and specifi c mortality were calculated by age group, sex and etiological classifi cation using adjusted and crude rates. Rates were age-adjusted using the direct method, and the population from the 2002 Census of Population and Housing was considered as the standard population. Percentages and means were also calculated according to selected variables and the relative risk of death due to the disease according to sex, age group and etiological classifi cation. The trend and forecast for mortality rates were estimated for this disease.
RESULTS The crude mortality rate from cirrhosis of the liver was 9.0 per 100,000 population for the period. Those aged ≥75 years had the highest risk of death (48.3 per 100,000 population). The crude and adjusted mortality rates were almost double for men (12.4 vs. 5.6 and 11.7 vs. 5.6 per 100,000 population, respectively), as was the total relative risk of death, which was 2.2 times higher. Nonalcoholic cirrhosis accounted for 71.6% of deaths. By the end of 2017, risk of death from cirrhosis had climbed to 14.8 per 100,000 population (adjusted rate: 10.6 per 100,000 population), a signal that mortality had progressively increased over the 31 years analyzed. In addition, forecasts predict that death rates will continue their gradual increase, reaching 19.2 per 100,000 population in 2025.
CONCLUSIONS Deaths from cirrhosis of the liver constitute a substantial health burden in Cuba. The upward trend and forecast, in addition to increased risk of mortality in men and older adults, are similar to those reported internationally. The fi nding that most of these deaths result from nonalcoholic cirrhosis should be further studied, as formulation of effective public health strategies depends largely on attaining a better understanding of the etiology, progression and social determinants of the disease.


REFERENCES

  1. Ginés P, Arroyo V. Cirrosis hepática. In: Farreras R, editor. Medicina Interna. 17th ed. Madrid: Elsevier; 2012. p. 314−9. Spanish.

  2. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990– 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Mar 1;5(3):245–66.

  3. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol [Internet]. 2019 [cited 2020 Mar 11];70(1):151–71. Available at: https://www.journal-of-hepatology .eu/article/S0168-8278(18)32388-2/abstract

  4. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 1970. Havana: Ministry of Public Health (CU); 1970. Spanish.

  5. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2017 [Internet]. Havana: Ministry of Public Health (CU); 2018 Apr [cited 2020 Mar 15]. 206 p. Available at: http://fi les.sld.cu/dne/fi les/2017/05/anua rio-2017-esp-e.pdf. Spanish.

  6. Pan American Health Organization. Manual de la Clasifi cación Internacional de Enfermedades, Traumatismos, y Causas de Defunción CIE-9. Vol. 2 [Internet]. Washington, D.C.: Pan American Health Organization; 2003 [cited 2020 Mar 8]. 173 p. Available at: http://ais.paho.org/classifi cations/Chapters/pdf/ Volume2.pdf. Spanish.

  7. Pan American Health Organization. Clasifi cación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima revisión. (CIE-10) Manual de Instrucciones. Décima revisión. Vol. 1. Washington, D.C.: Pan American Health Organization; 2003 [cited 2020 Mar 8]. 1177 p. Available at: https://iris.paho.org/ bitstream/handle/10665.2/6282/Volume1.pdf. Spanish.

  8. INFOMED [Internet]. Havana: Ministry of Public Health (CU); c2020. Publicaciones. Health Care Situation in Cuba. Basic Indicators; [cited 2020 Mar 8]. Available at: https://temas.sld.cu/estadis ticassalud/publicaciones-2/health-care-situation -in-cuba-basic-indicators/. Spanish.

  9. National Bureau of Statistics and Information (CU). Censo Nacional de Población y Viviendas. Havana:National Bureau of Statistics and Information (CU); 2002. Spanish.

  10. Chatfi eld C. The analysis of time series: an introduction. 6th ed. Florida: Chapman & Hall; 2004.

  11. Arús Soler E, Pérez Brioso NA, Parrilla Delgado M, Domínguez Álvarez C. Antifi brotic effect of recombinant interferon alfa 2b in liver cirrhosis caused by virus B or C. Rev Cubana Med [Internet]. 2005 May–Aug [cited 2020 Mar 11];44(3– 4). Available at: http://scielo.sld.cu/scielo .php?script=sci_arttext&pid=S0034-752320 05000400008&lng=es. Spanish.

  12. Ramírez-Soto M, Guevara-Cuadros J, Huichi- Atamari M. Mortalidad por hepatocarcinoma y cirrosis hepática en Apurímac: 2007-2010. Rev Perú Epidemiol [Internet]. 2012 Jan–Apr [cited 2017 Nov 12];16(1):1−5. Available at: http://www .redalyc.org/pdf/2031/203124341008.pdf. Spanish.

  13. Ojeda Morales R, Más Bermejo P, Castell-Florit Serrate P, Arocha Mariño C, Valdivia Onega NC, Druyet Castillo D, et al.. Transformaciones en el sistema de salud en Cuba y estrategias actuales para su consolidación y sostenibilidad. Rev Panam Salud Pública. 2018 Apr 24;42:e25. DOI: 10.26633/RPSP.2018.25. Spanish.

  14. Castellanos Suárez J, Infante Velázquez M, Pérez Lorenzo M, Umpiérrez García I, Fernández Báez A. Caracterización clínica de pacientes con cirrosis hepática en el Hospital Militar Docente Dr. Mario Muñoz, de Matanzas. Rev Méd Electrón [Internet]. 2012 Nov–Dec [cited 2020 Mar 16];34(6):624−37. Available at: http:// scielo.sld.cu/scielo.php?script=sci_arttext&pid =S1684-18242012000600001. Spanish.

  15. Fajardo González MH, Arce Núñez M, Medina Garrido Y, Esteva Carral L, Osorio Pagola MF. Comportamiento de la cirrosis hepática en el hospital “Arnaldo Milián Castro” de julio de 2007 a marzo de 2009. MediSur [Internet]. 2010 Jul–Aug [cited 2020 Feb 12];8(4):40–8. Available at: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S1727 -897X2010000400007. Spanish.

  16. Roque Lozano JA, Sauchay Romero L, Rodríguez Chala HE. Caracterización de mortalidad por cirrosis hepática en el Hospital “Julio Trigo López”. 2012 a 2016. Rev Cubana Tecnol Salud [Internet]. 2019 Apr–Jun [cited 2020 Apr 3];10(2):35–43. Available at: http://www.revtec nologia.sld.cu/index.php/tec/article/view/1310. Spanish.

  17. Torreblanca Xiques A, Fonseca Chong L. Caracterización de los pacientes con cirrosis hepática atendidos en Las Tunas. Rev Electrón Dr. Zoilo Marinello [Internet]. 2014 [cited 2020 Mar 31];39(12). Available at: http://revzoilomarinello .sld.cu/index.php/zmv/article/view/121. Spanish.

  18. Dalmau-Bueno A, García-Altés A, Mari-Dell’Olmo M, Pérez K, Espelt A, Kunst AE, et al. Trends in socio-economic inequalities in cirrhosis mortality in an urban area of Southern Europe: a multilevel approach. J Epidemiol Comm Health [Internet]. 2010 Aug [cited 2020 Mar 31];64(8):720–7. Available at: https://www.jstor.org/stable/40794069

  19. Erskine S, Maheswaran R, Pearson T, Demrmot G. Socioeconomic deprivation, urban-rural location and alcohol-related mortality in England and Wales. BMC Pub Health [Internet]. 2010 Feb 25 [cited 2020 Feb 13];10:99. Available at: https://bmcpublichealth.biomedcentral.com/ar ticles/10.1186/1471-2458-10-99

  20. Colectivo de autores. III Encuesta Nacional de Factores de Riesgo y Actividades Preventivas de Enfermedades No Transmisibles 2010–2011 [Internet]. Havana: Editorial Ciencias Médicas; 2014 [cited 2020 Mar 12]. Available at: https://especia lidades.sld.cu/higienepidemiologia/2014/08/23/ iii-encuesta-nacional-de-factores-de-riesgo-y -actividades-preventivas-de-enfermedades-no -trasmisibles-cuba-2010-2011/. Spanish.

  21. World Health Organization. Informe Mundial de Situación sobre Alcohol y Salud 2018. Resumen. (OPS/NMH/19-012). Licencia: CC BY-NC-SA 3.0 IGO. Washington, D.C.: Pan American Health Organization; 2019. Spanish.

  22. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol [Internet]. 2013 Jul 1 [cited 2020 Mar 8];59(1):160–8. Available at: https://www.journal-of-hepatology .eu/article/s0168-8278(13)00184-0/fulltext

  23. Pérez Lorenzo M, Duarte Castillo N, Montero González T, Franco Estrada S, Winograd Lay R, Brizuela Quintanilla RA. Prevalencia del hígado graso no alcohólico en muestras de biopsias hepáticas. Rev Cub Med Mil [Internet]. 2006 Oct–Dec [cited 2020 Mar 11];35(4). Available at: http://scielo.sld.cu/ scielo.php?script=sci_arttext&pid=S0138 -65572006000400006&lng=es. Spanish.

  24. Castellanos Fernández MI. La importancia de la desnutrición en el pronóstico del paciente con cirrosis hepática [thesis] [Internet]. [Havana]: Universidad de Ciencias Médicas de La Habana. Facultad de Ciencias Médicas “General Calixto García”; 2017 [cited 2020 Mar 8]. 156 p. Available at: http://tesis.sld.cu/index .php?P=FullRecord&ID=391. Spanish.

  25. Pedroso Flaquet P. Aportes a la evaluación de la vacuna recombinante cubana contra la hepatitis B [thesis] [Internet]. [Havana]: “Pedro Kourí” Institute of Tropical Medicine (CU); 2009 [cited 2020 Mar 8]. 142 p. Available at: http://tesis.sld .cu/index.php?P=FullRecord&ID=496. Spanish.

  26. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet [Internet]. 2012 Dec 15 [cited 2020 Mar 8];380(9859):2095–128. Available at: https:// www.ncbi.nlm.nih.gov/pubmed/23245604

  27. Padrón G, Arús E, Roca J, Viña A, Lemus G, Bacallao J. The hepatitis C in Cuba: prevalence, antibody pattern, genotype and risk factor. Hepatology. 1994;19(4):141.

  28. Vázquez Torres Y, Infante Velázquez M, Miranda Gómez O, Vázquez Torres YC, Vázquez Anovega H, Torres Sánchez C, et al. Detección de anticuerpos contra el virus de la hepatitis C en donantes de sangre voluntarios. Rev Cubana Med Gen Integr [Internet]. 2017 Oct–Dec [cited 2020 Apr 2];35(4). Available at: http://scielo.sld .cu/scielo.php?script=sci_arttext&pid=S0864 -21252017000400002&lng=es. Spanish.

  29. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol [Internet]. 2016 Sep 14 [cited 2019 Nov 2];22(34):7824–40. Available at: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC5016383/

  30. Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology [Internet]. 2019;69(6):2672–82. Available at: https://www .ncbi.nlm.nih.gov/pubmed/30179269




2020     |     www.medigraphic.com